Clinical Trials · NCT07423247
Tirzepatide (Spartina) in Obese Kidney Transplant Recipients
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 30
- Start date
- Jan 2026
- Locations
- 1 site, Iran
- Primary endpoint
- Percent Change in Body Weight From Baseline at Week 24